$Direxion Daily TSLA Bull 2X Shares(TSLL)$ $Tesla Motors(TSLA)$ Managed to make some small profit again from intraday trading on CBA. Entered TSLL at an average of $14.70 when TSLA was trading around $337-$339. Exited the full position at $15.30 as TSLA rebounded from $337 to ~$347 capturing the momentum swing cleanly. Support Levels: $337 (prior day's high), $320, and $313–$314 Next Resistance: $360 Key Level Today: TSLA needs to hold $345 for continuation to the upside. Fun Fact: TSLA is now officially trading above its 200-day SMA which is a strong bullish signal. Why is this important? The 200SMA acts as a long-term trend indicator. Trading above it often signals a shift in sentimen
$NVDA 20260320 75.0 PUT$ Added the March 2026 $75 put on $NVDA. This is a deep out-of-the-money, long-term hedge—designed more as a low-cost insurance play than a high-conviction directional bet. Plenty of time on the clock here. Letting the position sit and do its job while the broader portfolio stays active. Will revisit if market structure changes.
$SQQQ VERTICAL 250620 CALL 50.0/CALL 30.0$ Assigned price at $50. However, doesn't make sense to sell calls at $50 as the premiums will be too slow. Did a balanced approach by selling nearer to the money calls at $30 with long call at $50. If there is a rally, the long call will ensure that will still have some profits to be made instead of just getting stock called away at a loss
If you’ve been fixated on the news flow around tariffs and stuck on the old narrative that Europe is doomed and can only regulate vs innovate then you might have missed the fact that European equities are up over +10% YTD.Change is in the air, a key set of breakouts and improving technicals serve as a timely prompt to consider whether there’s more to this —and more left in the move…What’s driving the strength in European Equities:Valuations: unlike expensive US stocks, European stocks are still cheap/reasonably priced, and trade at a record low valuation discount vs US. The thing I always emphasize is that when valuations reach such extremes they have a habit of speaking for themselves; the rubber band eventually snaps back.Monetary Policy: the European Central Bank began rate cuts earlier
🎁 Bet on Alibaba Stock Movement and Win Tiger Coins!
Hi, Tigers!Welcome to Daily Discussion! This is the place for you to share your trading ideas and win coins!Click here to join the Topic & Win coins >>[Rewards]We will reward you with 50 Tiger Coins when you share your knowledge about stocks and markets here, depending on quality and originality.[Winners Announcement:14 May]1.Here are the 6 Tigers whose post has the best quality & interaction yesterday:Congratulations on being offered 50 Tiger Coins!Can Snow
Is UnitedHealth (UNH) a Buy, Hold, or Sell? Breaking Down the Collapse
UnitedHealth Group (UNH), once a pillar of stability and growth in the healthcare sector, has seen its stock price plunge nearly 50% in just six months, erasing billions in market cap and rattling investor confidence. From its 52-week high of $630.73, the stock has nosedived to around $311, prompting many to ask: Is this stock broken—or is the company itself fundamentally broken? In this breakdown, we'll cover what’s gone wrong, why sentiment is this bad, and whether now could actually be the best time in over a decade to consider buying. Why UNH Stock Is Getting Crushed A perfect storm of negative catalysts has slammed UnitedHealth. Let’s walk through them: 1. The Largest Healthcare Data Breach in U.S. History It began with a cyberattack on UnitedHealth’s tech unit (Change Healthcare), fi
Bullish on Incannex Healthcare (IXHL): Clinical Breakthrough Ignites Upside Potential
Incannex Healthcare Inc. (IXHL) has recently captured market attention with a staggering 720.63% surge on May 14, 2025, closing at $0.70 and potentially climbing to $1.18 in after-hours trading. As a clinical-stage biopharmaceutical company focused on chronic disease treatments, IXHL is poised for further gains, driven by its innovative pipeline and market potential. First, IXHL’s flagship product, IHL-42X, has made significant strides in treating obstructive sleep apnea (OSA). On May 14, the company announced the completion of patient dosing in the Phase 2 portion of its Phase 2/3 RePOSA study, with preliminary results expected in July. The OSA market is vast, with current treatments suffering from poor compliance. A successful IHL-42X could address this gap, drawing significant investor
$SPDR S&P 500 ETF Trust(SPY)$ is 4% away from all time highs and $Tesla Motors(TSLA)$ is 40% away. Everyone thinks they missed the move.But, this is just the beginning. Look at $Alphabet(GOOG)$$Alphabet(GOOGL)$ chart. Its about to explode towards $193-$202 gap area.Here's why I think it will go a lot higher There are 2 areas of resistance that GOOG must cross here 1) 200SMA at $172 and 2) hard resistance at $170. Yes, they are very close to each other. This is a confluence of selling pressure.But, study this chart closely. All gaps on GOOG chart always get filled. This chart will eventually breakout towards $200 and